PT99358A - Processo para a preparacao de composicoes farmaceuticas contendo aminoglicosidos e de reduzida nefrotoxicidade induzida por xantinas - Google Patents

Processo para a preparacao de composicoes farmaceuticas contendo aminoglicosidos e de reduzida nefrotoxicidade induzida por xantinas

Info

Publication number
PT99358A
PT99358A PT99358A PT9935891A PT99358A PT 99358 A PT99358 A PT 99358A PT 99358 A PT99358 A PT 99358A PT 9935891 A PT9935891 A PT 9935891A PT 99358 A PT99358 A PT 99358A
Authority
PT
Portugal
Prior art keywords
group
carbon atoms
chain
chem
stands
Prior art date
Application number
PT99358A
Other languages
English (en)
Other versions
PT99358B (pt
Inventor
William J Novick Jr
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of PT99358A publication Critical patent/PT99358A/pt
Publication of PT99358B publication Critical patent/PT99358B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
PT99358A 1990-10-30 1991-10-29 Processo para a preparacao de composicoes farmaceuticas contendo aminoglicosidos e de reduzida nefrotoxicidade induzida por xantinas PT99358B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/606,018 US5039666A (en) 1990-10-30 1990-10-30 Aminoglycoside composition having substantially reduced nephrotoxicity induced by the aminoglycoside

Publications (2)

Publication Number Publication Date
PT99358A true PT99358A (pt) 1992-09-30
PT99358B PT99358B (pt) 1999-03-31

Family

ID=24426160

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99358A PT99358B (pt) 1990-10-30 1991-10-29 Processo para a preparacao de composicoes farmaceuticas contendo aminoglicosidos e de reduzida nefrotoxicidade induzida por xantinas

Country Status (16)

Country Link
US (1) US5039666A (pt)
EP (1) EP0483634B1 (pt)
JP (1) JP3003333B2 (pt)
KR (1) KR0139199B1 (pt)
AT (1) ATE133072T1 (pt)
AU (1) AU640056B2 (pt)
CA (1) CA2054471C (pt)
DE (1) DE69116503T2 (pt)
DK (1) DK0483634T3 (pt)
ES (1) ES2083500T3 (pt)
GR (1) GR3018824T3 (pt)
HU (1) HU213509B (pt)
IE (1) IE70670B1 (pt)
IL (1) IL99874A (pt)
PT (1) PT99358B (pt)
ZA (1) ZA918592B (pt)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT584347E (pt) * 1992-03-04 2003-06-30 Cell Therapeutics Inc Compostos de xantina hidroxilados enantiomericos
JP3076672B2 (ja) * 1992-06-18 2000-08-14 三井化学株式会社 キノリン誘導体のフマル酸塩
US5288721A (en) * 1992-09-22 1994-02-22 Cell Therapeutics, Inc. Substituted epoxyalkyl xanthines
US5817662A (en) * 1992-11-09 1998-10-06 Cell Therapeutics, Inc. Substituted amino alkyl compounds
US5340813A (en) * 1992-11-09 1994-08-23 Cell Therapeutics, Inc. Substituted aminoalkyl xanthine compounds
US5780476A (en) * 1992-11-16 1998-07-14 Cell Therapeutics, Inc. Hydroxyl-containing xanthine compounds
US5473070A (en) * 1992-11-16 1995-12-05 Cell Therapeutics, Inc. Substituted long chain alcohol xanthine compounds
US6469017B1 (en) * 1998-01-16 2002-10-22 Cell Therapeutics, Inc. Method of inhibiting interleukin-12 signaling
US6693105B1 (en) 1992-11-16 2004-02-17 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US5866576A (en) * 1992-12-16 1999-02-02 Cell Therapeutics, Inc. Epoxide-containing compounds
WO1994015605A1 (en) * 1993-01-14 1994-07-21 Cell Therapeutics, Inc. Acetal or ketal substituted therapeutic compounds
AU6092794A (en) * 1993-01-19 1994-08-15 Cell Therapeutics, Inc. Oxime-substituted therapeutic compounds
US5837703A (en) * 1993-03-31 1998-11-17 Cell Therapeutics, Inc. Amino-alcohol substituted cyclic compounds
US5641783A (en) * 1993-11-12 1997-06-24 Cell Therapeutics, Inc. Substituted amino alcohol compounds
US6020337A (en) * 1993-04-05 2000-02-01 Cell Therapeutics, Inc. Electronegative-substituted long chain xanthine compounds
CA2192470A1 (en) * 1994-01-14 1995-07-20 Paul A. Brown Method for treating diseases mediated by cellular proliferation in response to pdgf, egf, fgf and vegf
US6878715B1 (en) * 1994-02-18 2005-04-12 Cell Therapeutics, Inc. Therapeutic compounds for inhibiting interleukin-12 signals and method for using same
US6103730A (en) * 1994-03-24 2000-08-15 Cell Therapeutics, Inc. Amine substituted compounds
WO1995022546A1 (en) * 1994-02-18 1995-08-24 Cell Therapeutics, Inc. Intracellular signalling mediators
US5807861A (en) * 1994-03-24 1998-09-15 Cell Therapeutics, Inc. Amine substituted xanthinyl compounds
US5801182A (en) * 1994-03-24 1998-09-01 Cell Therapeutics, Inc. Amine substituted compounds
US6075029A (en) * 1998-01-02 2000-06-13 Cell Therapeutics, Inc. Xanthine modulators of metabolism of cellular P-450
DE19823396A1 (de) * 1998-05-26 1999-12-02 Bayer Ag Synergistische insektizide Mischungen
US20020061281A1 (en) * 1999-07-06 2002-05-23 Osbakken Robert S. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) * 1999-07-06 2003-06-10 Sinuspharma, Inc. Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US20030207901A1 (en) * 1999-07-27 2003-11-06 Cell Therapeutics, Inc. Hydroxyl-containing compounds
US6586429B2 (en) * 2000-11-29 2003-07-01 Cell Therapeutics, Inc. Tricyclic fused xanthine compounds and their uses
US6825180B2 (en) * 2001-05-18 2004-11-30 Cell Therapeutics, Inc. Pyridopyrimidine compounds and their uses
US7345018B2 (en) 2002-04-25 2008-03-18 Reception Aps Method of treating side effects induced by therapeutic agents
EA200501518A1 (ru) * 2003-03-26 2006-04-28 Ресептикон Апс Применение соединений для профилактики лекарственно-индуцированной клеточной токсичности
CN101076372A (zh) * 2004-10-06 2007-11-21 里斯普蒂康公司 化合物用于预防药物诱导的细胞毒性的用途
US7439343B2 (en) * 2005-09-01 2008-10-21 Rensselaer Polytechnic Institute Aminoglycoside-polyamine displacers and methods of use in displacement chromatography
WO2009152202A2 (en) * 2008-06-11 2009-12-17 Utah State University New aminoglycosides: synthesis and use as antifungals
WO2012082650A2 (en) 2010-12-14 2012-06-21 Utah State University Aminoglycosides:synthesis and use as antifungals
US9669044B2 (en) 2010-12-14 2017-06-06 Utah State University Aminoglycoside and azole compositions and methods

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029882A (en) * 1974-03-19 1977-06-14 Schering Corporation Selective acylation of the C-1 amino group of aminoglycoside antibiotics
US4002742A (en) * 1974-03-19 1977-01-11 Schering Corporation 1-N-alkyl-4,6-di-(aminoglycosyl)-1,3-diaminocyclitols, methods for their manufacture, methods for their use as antibacterial agents, and compositions useful therefor
US4235892A (en) * 1979-02-05 1980-11-25 Schering Corporation, Patent Dept. 1-Aryl-2-acylamido-3-fluoro-1-propanols, methods for their use as antibacterial agents and compositions useful therefor
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
EP0414175A3 (en) * 1989-08-22 1992-04-01 Hoechst Aktiengesellschaft Use of xanthine derivatives to reduce nephrotoxicity

Also Published As

Publication number Publication date
ATE133072T1 (de) 1996-02-15
ZA918592B (en) 1992-07-29
AU640056B2 (en) 1993-08-12
GR3018824T3 (en) 1996-04-30
KR0139199B1 (ko) 1998-05-15
CA2054471A1 (en) 1992-05-01
JP3003333B2 (ja) 2000-01-24
DE69116503T2 (de) 1996-06-20
IE913775A1 (en) 1992-05-22
DK0483634T3 (da) 1996-05-20
IL99874A0 (en) 1992-08-18
JPH04282315A (ja) 1992-10-07
HUT60136A (en) 1992-08-28
IL99874A (en) 1995-08-31
KR920007630A (ko) 1992-05-27
IE70670B1 (en) 1996-12-11
US5039666A (en) 1991-08-13
PT99358B (pt) 1999-03-31
EP0483634B1 (en) 1996-01-17
ES2083500T3 (es) 1996-04-16
EP0483634A2 (en) 1992-05-06
AU8680291A (en) 1992-05-07
HU913392D0 (en) 1992-01-28
DE69116503D1 (de) 1996-02-29
HU213509B (en) 1997-07-28
CA2054471C (en) 1998-09-22
EP0483634A3 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
PT99358A (pt) Processo para a preparacao de composicoes farmaceuticas contendo aminoglicosidos e de reduzida nefrotoxicidade induzida por xantinas
IL103301A (en) Pyrimidine nucleoside derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
AU660469B2 (en) Pharmacologically active hydrazine derivatives and processes for the preparation thereof
PT89623A (pt) Processo de preparacao de derivados de indolcarbazolo e de composicoes farmaceuticas contendo esses compostos
SE8006498L (sv) Karbostyrilderivat samt forfarande for framstellning av dem
BR9604907B1 (pt) derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral e composição contendo derivados de nucleosidios homocarbociclico de pirimidinodiona substituìda antiviral com princìpios ativos.
KR920009397A (ko) 사람 레트로바이러스의 복제를 억제하는데 효과적인 약제를 제조하기 위한 크산틴의 용도
MA20829A1 (fr) Nouvelles anthracyclines et compositions les contenant
ES8105319A1 (es) Procedimiento de preparacion de derivados pirazolo (1,5-c) quinazolinos y de sus sales de adicion acidas
YU128191A (sh) Postupak za dobijanje 6-acilnih, 7-acilnih i 6,7-diacilnih analoga forskolina i njegovih intermedijata
ATE24887T1 (de) Cycloaliphatische alkohole.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920427

FG3A Patent granted, date of granting

Effective date: 19981207

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20000630